ScoreWhy is Alembic Pharmaceuticals Ltd. ?
1
Poor long term growth as Operating profit has grown by an annual rate -9.97% of over the last 5 years
2
Flat results in Mar 26
- OPERATING PROFIT TO INTEREST (Q) Lowest at 10.10 times
- PBDIT(Q) Lowest at Rs 227.92 cr.
- OPERATING PROFIT TO NET SALES (Q) Lowest at 12.34%
3
Underperformed the market in the last 1 year
- Even though the market (BSE500) generated negative returns of -3.06% in the last 1 year, its fall in the stock was much higher with a return of -25.20%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Alembic Pharma for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Alembic Pharma
-25.35%
-0.94
27.76%
Sensex
-8.85%
-0.65
13.06%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.37%
EBIT Growth (5y)
-9.97%
EBIT to Interest (avg)
14.29
Debt to EBITDA (avg)
1.02
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
1.03
Tax Ratio
3.33%
Dividend Payout Ratio
37.06%
Pledged Shares
0
Institutional Holding
20.41%
ROCE (avg)
11.33%
ROE (avg)
10.96%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
34
Price to Book Value
2.55
EV to EBIT
19.61
EV to EBITDA
14.02
EV to Capital Employed
2.27
EV to Sales
2.14
PEG Ratio
0.70
Dividend Yield
1.50%
ROCE (Latest)
11.59%
ROE (Latest)
12.93%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
PAT(9M)
At Rs 579.64 cr has Grown at 32.40%
EPS(Q)
Highest at Rs 10.31
-10What is not working for the Company
OPERATING PROFIT TO INTEREST (Q)
Lowest at 10.10 times
PBDIT(Q)
Lowest at Rs 227.92 cr.
OPERATING PROFIT TO NET SALES (Q)
Lowest at 12.34%
PBT LESS OI(Q)
Lowest at Rs 117.88 cr.
Loading Valuation Snapshot...
Here's what is working for Alembic Pharma
Profit After Tax (PAT) - Quarterly
At Rs 227.46 cr has Grown at 45.0%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 227.46 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 10.31
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Alembic Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 117.88 cr has Fallen at -33.68%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Operating Profit to Interest - Quarterly
Lowest at 10.10 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Profit (PBDIT) - Quarterly
Lowest at Rs 227.92 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Lowest at 12.34%
in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 117.88 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Non Operating Income - Quarterly
Highest at Rs 25.50 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
